Poor NPSP is doomed to only collect about 100 million dollars a year because the additional indication for Sensipar didn't make it. Their 2 drugs that they are applying for approval from the FDA this year are unimpaired and yet the stock is down about 15%. I for one didn't even know about any additional indications for Sensipar and judging by the fact that nobody who followed the stock either knew, ever talked about or cared about this, the selloff is remarkable. I believe the short sellers who were getting caught in this stock before the selloff saw this as an opportunity to scare some sheep and recover their short selling losses. Its just absurd and stupid.